Aveanna Healthcare Holdings, Inc. (AVAH) company profile
Close on Nov 17, 2026Market cap $2.54BP/E 9.5Yield –
About Aveanna Healthcare
Services-Home Health Care Services, SIC 8082
Aveanna Healthcare Holdings Inc. provides home-based healthcare services tailored for patients with complex medical conditions. The company operates through three principal reporting segments: Private Duty Services, Home Health and Hospice, and Medical Solutions. Its clinical offerings include private duty nursing, pediatric therapy, home health, and hospice care. Caregivers, including registered and licensed practical nurses, deliver skilled support such as ventilator management, medication administration, feeding tube assistance, and pain therapies. The company serves individuals ranging from newborns and children discharged from intensive care units to young adults and senior citizens who require continuous medical attention.
The company functions across the United States as a provider of private duty nursing services, offering in-home clinical care up to twenty-four hours a day, seven days a week. Its principal executive offices are located in Atlanta, Georgia.
Summary of the business section of Aveanna Healthcare's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Aveanna Healthcare Holdings, Inc.
- Founded
- 2016
- Headquarters
- Atlanta, GA
- Address
- 400 Interstate North Parkway, Ste 1700 30339
- Phone
- (770) 441-1580
- Website
- aveanna.com
- Employees
- 32,000, Jan 3, 2026
- Industry
- Services-Home Health Care Services
- Incorporated in
- Delaware
- Fiscal year ends
- January 1
- Auditor
- Ernst & Young LLP, Atlanta, Georgia
Stock & identifiers
- Ticker
- AVAH
- Exchange
- Nasdaq
- IPO date
- Apr 30, 2021
- Shares outstanding
- 218M, Aug 7, 2026
- Public float
- $349.70M, Jun 28, 2025
- Filer category
- Accelerated filer
- SEC CIK
- 1832332
- CUSIP
- 05356F105
- ISIN
- US05356F1057
- FIGI
- BBG00G6D6H96
- Share class FIGI
- BBG00G6D6HB3
- EIN
- 84-4717209
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Deborah Stewart | SVP, Chief Accounting Officer | 377,844 |
| Edwin C. Reisz | Chief Administrative Officer | 1,397,897 |
| Jeff Shaner | Chief Executive Officer | 2,561,972 |
| Patrick A. Cunningham | Chief Compliance Officer | 212,755 |
| Matthew Buckhalter | Chief Financial Officer | 529,243 |
| Jerry Perchik | Chief Legal Officer | 440,530 |
| Rodney D. Windley | Director | 2,078,017 |
| Samuel Altman Weil | Director | – |
| Brent D. Layton | Director | 54,258 |
| Victor F. Ganzi | Director | 502,522 |
| Erica Schwartz | Director | 276,414 |
| Steven E. Rodgers | Director | 312,414 |
| Sheldon M. Retchin | Director | 324,746 |
CEO pay and shareholder return
Pay versus performance table from the proxy statement
| Fiscal year | CEO total pay | CEO pay actually paid | Other executives (avg) | Value of $100 invested | Peer group |
|---|---|---|---|---|---|
| FY2025 | $4.86M | $17.89M | $1.95M | $1036 | – |
| FY2024 | $4.54M | $10.56M | $2.05M | $597 | – |
| FY2023 | $2.91M | $5.69M | $1.87M | $344 | – |
| FY2022 | $5.31M | -$2.62M | $2.40M | $11 | – |
| FY2021 | $3.24M | -$6.69M | $2.77M | $49 | – |
“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.
Executive compensation, fiscal 2025
Summary compensation table from the latest proxy statement
| Executive | Salary | Stock awards | Incentive pay | Other | Total | vs. prior year |
|---|---|---|---|---|---|---|
| Jeffrey Shaner Chief Executive Officer (PEO) | $750.00K | $2.60M | $1.50M | $10.17K | $4.86M | +7% |
| Matthew Buckhalter Chief Financial Officer (PFO) | $468.75K | $701.50K | $750.00K | $10.07K | $1.93M | +13% |
| Ed Reisz Chief Administrative Officer | $450.00K | $836.44K | $675.00K | $9.58K | $1.97M | +20% |
Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.
IPO
From the final prospectus (Form 424B4) and the first day of trading
Offering
- Type
- Initial public offering
- Final prospectus filed
- Apr 30, 2021
- Offer price
- $12.00
- Securities offered
- 38,236,000
- Gross proceeds
- $458.83M
- Exchange
- Nasdaq
- First trading day
- Apr 28, 2021
- First-day close
- $12.000.0%
- Lock-up ends (est.)
- Oct 25, 2021
“The initial public offering price of our common stock is $12.00 per share.”
Lock-up end is estimated as 180 days after the first trading day; the prospectus sets the actual terms.
Employees
Headcount reported in annual reports
“As of January 3, 2026, we employed approximately 3,500 full-time support staff personnel with the remainder of our 32,000 employees employed on a part-time, temporary, per-diem or full-time basis.”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Dec 27, 2022 | Listing notice | Notice of delisting or failure to satisfy a listing rule (8-K Item 3.01) |
| Dec 16, 2021 | Acquisition / sale | Completion of acquisition or disposition of assets (8-K Item 2.01) |
| Apr 30, 2021 | IPO | Initial public offering priced (424B4 prospectus) |
| Apr 26, 2021 | Listing | Registration of securities on an exchange (Form 8-A) |
See a number that looks wrong?